Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Wins European Patent for Mass Spec-Based Genotyping

NEW YORK, Dec. 11 (GenomeWeb News) - Sequenom has won a European patent covering "processes for detecting target nucleic acid sequences in a biological sample using mass spectrometry," the company said today.


The patent, EP0815261B1, is called "DNA Diagnostics Based on Mass Spectrometry," and "relates to several patents previously issued in the United States.


The award validates the technology in 14 European countries: Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, and Switzerland, Sequenom said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.